Cross-Sectional Patient-Reported Outcomes in Chronic Lymphocytic Leukemia Patients

Real-world health-related quality of life (HRQoL) and treatment satisfaction data of patients with CLL.
This study was completed in two parts. The first portion (Norming Study) was a US online survey conducted to serve as a reference population. The Norming Study included a total of 139 patients with CLL, excluding those treated with ibrutinib. The second portion (CLL Ibrutinib Study). Respondents completed online or phone surveys to collect demographic and clinical information and HRQoL instruments. Higher scores indicate better HRQoL/treatment satisfaction.